KINETA, INC.

Profile

Company Names

KINETA, INC.

Addresses

219 TERRY AVE. N., SUITE 300, SEATTLE, WA 98109-5208

219 TERRY AVE N., 3RD FLOOR, SEATTLE, WA 98109

219 TERRY AVE. N., 3RD FLOOR, SEATTLE, WA 98109

219 TERRY AVE N., SUITE 300, SEATTLE, WA 98109-5208

219 TERRY AVENUE NORTH, SUITE 300, SEATTLE, WA 98109

219 TERRY AVENUE NORTH, SUITE 300, SEATTLE, WA 98109

307 WESTLAKE AVENUE NORTH, SUITE 200, SEATTLE, WA 98109

Phone Numbers

2063780400
(206) 378-0400

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

WASHINGTON

Total Amount Raised:

$86,123,382.00

Number of Funding Rounds:

17
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
17
2022-02-22 
$2,400,000.00 
$15,000,000.00 
$12,600,000.00 
Debt 
16
2021-06-29 
$1,181,448.00 
$3,780,000.00 
$2,598,552.00 
Equity 
15
2021-05-28 
$17,397,819.00 
$27,297,815.00 
$9,899,996.00 
Equity 
14
2020-06-03 
$100,001.00 
$10,000,000.00 
$9,899,999.00 
Equity 
13
2019-10-17 
$2,950,100.00 
$3,001,850.00 
$51,750.00 
Debt 
12
2019-04-26 
$4,650,500.00 
$5,000,000.00 
$349,500.00 
Equity 
11
2018-09-13 
$7,060,315.00 
$15,000,000.00 
$7,939,685.00 
Equity 
10
2017-11-15 
$1,878,610.00 
$10,000,000.00 
$8,121,390.00 
Equity 
9
2017-11-02 
$2,496,546.00 
$6,100,000.00 
$3,603,454.00 
Debt 
8
2017-10-19 
$24,369,000.00 
$24,369,000.00 
$0.00 
Equity 
7
2017-09-15 
$9,000,000.00 
$9,005,167.00 
$5,167.00 
Debt 
6
2017-09-01 
$5,000,000.00 
$5,003,100.00 
$3,100.00 
Equity, Debt 
5
2017-02-20 
$47,250.00 
$4,000,000.00 
$3,952,750.00 
Debt 
4
2017-01-23 
$3,331,000.00 
$3,500,646.00 
$169,646.00 
Equity, Debt 
3
2016-06-06 
$1,752,688.00 
$4,500,000.00 
$2,747,312.00 
Debt 
2
2014-06-30 
$1,565,650.00 
$3,000,000.00 
$1,434,350.00 
Equity 
1
2009-12-31 
$942,455.00 
INDEFINITE 
INDEFINITE 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
 
BANKS 
EXECUTIVE OFFICER
DOTBLU INC   |  TAPJOY, INC.   |  EXPERIENCE PROJECT INC   |  GEARBOX, LLC   |  KINETA, INC.   |  VENTURI INVESTMENT PARTNERS II, L.P.   |  VIP REO, L.P.
RAYMOND 
 
BARTOSZEK 
DIRECTOR
KINETA, INC.   |  KINETA, INC./DE   |  RESPONDOLOGY HOLDINGS, INC.
WILLIAM 
 
CADWALLADER 
EXECUTIVE OFFICER
KINETA, INC.
CAMPION 
 
FELLIN 
EXECUTIVE OFFICER
KINETA, INC.
MARION 
 
FOOTE 
DIRECTOR
PRECISION IMAGE ANALYSIS, INC.   |  KINETA, INC.   |  ETA HOLDINGS, INC.
MARION 
R. 
FOOTE 
DIRECTOR
OTONEXUS MEDICAL TECHNOLOGIES, INC.   |  AVALARA INC   |  KINETA, INC.   |  KINETA, INC./DE
LUCIEN 
 
FOUKE III 
EXECUTIVE OFFICER
KINETA, INC.
ROBERT 
 
HEDEQUIST 
EXECUTIVE OFFICER
KINETA, INC.   |  KINETA CHRONIC PAIN, LLC   |  KINETA IMMUNO-ONCOLOGY, LLC   |  KV1.3 THERAPEUTICS, INC.
JIYOUNG 
 
HWANG 
DIRECTOR
KINETA, INC.
SHAWN 
 
IADONATO 
EXECUTIVE OFFICER, DIRECTOR
KINETA, INC.   |  KINETA IO, LLC   |  KPI THERAPEUTICS, INC.   |  KINETA VIRAL HEMORRHAGIC FEVER, LLC   |  KINETA IMMUNO-ONCOLOGY, LLC   |  KINETA CHRONIC PAIN, LLC   |  KV1.3 THERAPEUTICS, INC.   |  KINETA, INC./DE
PAULINE 
 
KENNY 
EXECUTIVE OFFICER, DIRECTOR
KINETA, INC.   |  KINETA, INC./DE
SHAWN 
 
LADONATO 
EXECUTIVE OFFICER, DIRECTOR
KINETA, INC.
CHARLES 
 
MAGNESS 
DIRECTOR, EXECUTIVE OFFICER
KINETA, INC.   |  KINETA HOLDINGS II, LLC   |  KINETA THREE, LLC   |  KINETA ONE, LLC
CHARLES 
L 
MAGNESS 
EXECUTIVE OFFICER, DIRECTOR
KINETA, INC.
DON 
 
MERLINO 
DIRECTOR
KPI THERAPEUTICS, INC.   |  KINETA, INC.
STEVEN 
 
MITCHELL 
DIRECTOR
KINETA, INC.
KENNETH 
 
NORTH 
EXECUTIVE OFFICER
KINETA, INC.
KEVIN 
 
OH 
DIRECTOR
KINETA, INC.
KYUNGWON 
 
OH 
DIRECTOR
KINETA, INC.
CRAIG 
 
PHILIPS 
EXECUTIVE OFFICER
KPI THERAPEUTICS, INC.   |  KV1.3 THERAPEUTICS, INC.   |  KINETA, INC.
RICHARD 
 
SAMUELSON 
DIRECTOR
KINETA, INC.   |  ODYSSEUS TECHNOLOGIES, INC.   |  SWAN HNW FUND LP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-06-15
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-05-28 
2022-03-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-02-22 
2021-11-24
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-05-28 
2021-07-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-06-29 
2021-06-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-05-28 
2020-11-06
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2017-09-01 
2020-11-06
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-10-17 
2020-11-06
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2017-01-23 
2020-11-06
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-09-15 
2020-06-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-03 
2020-05-21
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-26 
2020-02-25
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-10-17 
2019-10-21
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2017-01-23 
2019-10-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-10-17 
2019-09-26
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-11-02 
2019-05-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-26 
2019-02-07
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-11-02 
2018-11-30
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-15 
2018-09-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-09-13 
2017-11-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-15 
2017-11-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-11-02 
2017-10-23
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-19 
2017-09-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-09-15 
2017-09-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2017-09-01 
2017-09-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2017-09-01 
2017-02-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-02-20 
2017-02-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-02-20 
2017-01-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2017-01-23 
2016-06-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-06-06 
2014-07-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-06-30 
2010-01-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2009-12-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
ALTA COMPANIES LTD.
NONE